Mydecine Innovations Group Inc (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF), a Canada-based life sciences company, has named former Red Bull marketing executive, Jim Gunning, as its new chief marketing officer, it was reported on Friday.
Gunning has over two decades of experience in marketing. He has served as the managing director of RESQWATER and as a consultant for Blue Sky Biologicals.
In the new role, Gunning will be responsible for helping Mydecine to become a household name, and for developing a marketing campaign around the company's new fungtional mushroom product range under Mydecine Health Sciences, the company's operational branch. The fungtional mushroom product line should be on retail shelves across the US before the end of this year.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar